|
2025
|
G/S
|
Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoim... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of cancer; pharmaceut... |
|
|
G/S
|
Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s... |
|
|
G/S
|
Educational services, namely, providing on-line access to podcasts, videos and educational infor... |
|
|
G/S
|
Providing medical information in the field of cardiovascular
conditions, diseases, and disorders... |
|
|
G/S
|
Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical prepara... |
|
|
Invention
|
Method for enhancing production of genetically engineered autologous t cells.
The present invent... |
|
|
Invention
|
Engineering monoclonal antibodies to improve stability and production titer.
Presented herein ar... |
|
|
Invention
|
Offline troubleshooting and development for automated visual inspection stations.
In a method fo... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular disease... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of cancer and cardiovascular diseas... |
|
|
Invention
|
Solid state forms. The present disclosure provides crystalline and amorphous forms of 6-fluoro-7-... |
|
|
Invention
|
Torque driven drug delivery device.
An injector includes a housing having a syringe assembly and... |
|
|
G/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating oncology,... |
|
|
Invention
|
Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for ga... |
|
|
Invention
|
Lyophilized virus formulations.
Provided herein is a powder comprising a live, attenuated virus,... |
|
|
Invention
|
Needle shield removers, drug delivery devices, and related methods.
Needle shield removers, drug... |
|
|
G/S
|
Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment o... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer and imm... |
|
|
G/S
|
Pharmaceutical preparations, namely, ophthalmic preparations; pharmaceutical preparations for the... |
|
|
G/S
|
providing online information about sustainable manufacturing, development initiatives, and strate... |
|
|
Invention
|
Reducing viscosity of pharmaceutical formulations.
A method for reducing the viscosity of a phar... |
|
|
Invention
|
Mageb2 binding constructs.
The present invention relates to antibody constructs comprising a dom... |
|
|
G/S
|
Research and development of pharmaceutical preparations; research and development of pharmaceutic... |
|
|
Invention
|
Automated visual inspection image processing using gradient imaging techniques. A module may rece... |
|
|
Invention
|
Macrocyclic compounds as modulators of kras and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Processes for preparing macrocyclic compounds. The disclosure provides processes for preparing Co... |
|
|
Invention
|
Biomarkers for cancer therapeutics.
Biomarkers useful for identifying a variety of cancers that ... |
|
|
G/S
|
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
Invention
|
Solid forms of macrocyclic compounds and uses thereof. The disclosure provides solid forms of Com... |
|
|
Invention
|
Macrocyclic amino compounds as modulators of kras and uses therof. Disclosed herein are compounds... |
|
|
Invention
|
Solid state forms.
The present disclosure provides crystalline and amorphous HCl and HBr salt fo... |
|
|
Invention
|
Solid state forms of (2r,3s)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-n-(4-met... |
|
|
Invention
|
Data augmentation and encoding of multi-chain protein structures.
Described herein are technique... |
|
|
Invention
|
Pairing of two-chain constructs. The present invention relates to pairing of two chains of a mult... |
|
|
Invention
|
Data augmentation and encoding of multi-chain protein structures. Described herein are techniques... |
|
|
Invention
|
Method for predicting osmolality of protein solutions. The present disclosure relates to methods ... |
|
|
Invention
|
Drug delivery device. A drug delivery device may include a housing defining a longitudinal axis a... |
|
|
Invention
|
Tethered spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof. The present... |
|
|
Invention
|
Agonistic anti-il-2rbg heavy‑chain antibodies. Disclosed herein are heavy-chain antibodies having... |
|
|
Invention
|
Agonistic anti-il-2rbg heavy-chain antibodies.
Disclosed herein are heavy-chain antibodies havin... |
|
|
Invention
|
Gastrointestinal cancer treatments using mta-cooperative prmt5 inhibitors. Described herein are m... |
|
|
Invention
|
Method of assessing stopper movement in a drug delivery device. A method of assessing stopper mov... |
|
|
G/S
|
Providing medical information in the field of cardiovascular conditions, diseases, and disorders,... |
|
|
Invention
|
Methods of treating osteogenesis imperfecta. The invention is directed to a method of treating pe... |
|
|
Invention
|
Cancer treatments using mta-cooperative prmt5 inhibitors. Described herein are methods of treatin... |
|
|
G/S
|
Healthcare advisory services; medical advisory services; nutritional advisory services; pharmaceu... |
|
|
Invention
|
Glp-1 receptor agonists and their medical use. The present disclosure relates to improved GLP-1 r... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation and in... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of inflammation and i... |
|
|
Invention
|
Binding molecules for bcma and cd3.
The present invention relates to a binding molecule which is... |
|
|
Invention
|
Homogeneous antibody populations.
The present invention is generally directed to methods of prod... |
|
|
Invention
|
Stabilization of fc-containing polypeptides.
This disclosure provides polypeptides comprising an... |
|
|
Invention
|
Rnai constructs for inhibiting pnpla3 expression and methods of use thereof.
The present inventi... |
|
|
Invention
|
Tetravalent bispecific and tetraspecific antigen binding proteins and uses thereof.
The present ... |
|
2024
|
Invention
|
Processes of making and crystalline forms of a mdm2 inhibitor.
The present invention provides pr... |
|
|
Invention
|
Macrocyclic compounds and methods of use.
The present disclosure provides compounds useful for t... |
|
|
Invention
|
Treatment of eosinophilic esophagitis with anti-tslp antibody. The present disclosure, relates, i... |
|
2023
|
Invention
|
Formulations of human anti-rankl antibodies, and methods of using the same.
Disclosed herein are... |
|
|
Invention
|
Rnai constructs for inhibiting scap expression and methods of use thereof.
The disclosure relate... |
|
|
Invention
|
Processes for making nag-25, a carbohydrate targeting moiety, and its intermediates.
Provided he... |
|
|
Invention
|
Kif18a inhibition for treatment of cancer.
Provided herein are methods of determining a treatmen... |
|
|
Invention
|
Handheld drug delivery device |
|
2022
|
Invention
|
Vial sleeve |
|
2021
|
Invention
|
Stable cyclodextrin free carfilzomib formulation.
This disclosure provides a stable cyclodextrin... |
